FDA 执法报告 D-0073-2027:Ritedose 富马酸福莫特罗吸入溶液因杂质/降解规格不合格列为 II 类召回
FDA drug enforcement D-0073-2027: The Ritedose Corporation — Failed Impurities/Degradation Specification
FDA 执法报告 D-0073-2027 记录 The Ritedose Corporation 对批号 25BL0 的富马酸福莫特罗吸入溶液(20mcg/2mL)发起 II 类自愿召回,原因为杂质/降解规格不合格。
FDA drug recall enforcement report — D-0073-2027
Report issued: 2026-11-04. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "1 Technology Cir",
"address_2": "",
"center_classification_date": "20261023",
"city": "Columbia",
"classification": "Class II",
"code_info": "Lot: 25BL0, Expires: 02/28/2027",
"country": "United States",
"distribution_pattern": "Nationwide within the U.S",
"event_id": "100124",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {
"application_number": [
"ANDA216486"
],
"brand_name": [
"FORMOTEROL FUMARATE INHALATION SOLUTION"
],
"generic_name": [
"FORMOTEROL FUMARATE DIHYDRATE"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"Ritedose Pharmaceuticals, LLC"
],
"package_ndc": [
"76204-030-02",
"76204-030-01"
],
"product_ndc": [
"76204-030"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"RESPIRATORY (INHALATION)"
],
"rxcui": [
"1246319"
],
"spl_id": [
"459f276c-d771-4ae9-e063-6394a90a3476"
],
"spl_set_id": [
"2d9bf685-8886-4865-834b-2748af124b79"
],
"substance_name": [
"FORMOTEROL FUMARATE"
],
"unii": [
"W34SHF8J2K"
]
},
"postal_code": "29203-9591",
"product_description": "Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC",
"product_quantity": "3210 Cartons",
"product_type": "Drugs",
"reason_for_recall": "Failed Impurities/Degradation Specification",
"recall_initiation_date": "20261015",
"recall_number": "D-0073-2027",
"recalling_firm": "The Ritedose Corporation",
"report_date": "20261104",
"state": "SC",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov